
    
      The cardiac metabolic disturbance are assessed by a 18F-FDG PET/CT in the first week after
      SAH and monthly until normal result.

      The myocardial sympathetic innervation is assessed by a cardiac 123I-MIBG scintigraphy in the
      first week after SAH and six months later.

      Clinical outcome is assessed by Glasgow Outcome Scale, modified Rankin Scale and MOS-SF36 at
      1, 3 and 6 months after SAH.
    
  